Commodities

Jim Cramer goes over the best and worst Q3 performers in the S&P 500


CNBC’s Jim Cramer on Tuesday gave his take on the winning and losing stocks in the S&P 500 during the third quarter.”This is a harsh market with harsh criteria. Constellation Energy and Enphase can meet those criteria, but everything else in the winner’s circle seems capricious, and the losers? Just not enough there to take a risk,” he said.WinnersZoom In IconArrows pointing outwardsConstellation EnergyCramer said that the company is “perfectly crafted” for the ESG movement. Enphase”The stock is volatile, but it’s been a great buy on every dip. I bet that continues,” he said.EtsyCramer called the company the Amazon of hand-crafted goods.NetflixThe company’s stock should be able to continue gaining if Netflix doesn’t botch the launch of its ad-supported tier, he predicted.BiogenCramer said he has faith in the company’s Alzheimer’s drug, though he believes Eli Lilly’s will be better.LosersZoom In IconArrows pointing outwardsCharter CommunicationsCramer said that while the company’s profitable, it’s lack of growth means that its stock is going nowhere.FedExThe stock will likely be in the penalty box for at least three to six months after the company’s recent earnings miss and warnings of a worldwide recession, he said.Lumen TechnologiesCramer said he wouldn’t touch this stock with a 10 foot pole.CatalentThe Food and Drug Administration’s inspection of the company’s plant, which held up the distribution of Moderna’s Covid booster, likely hurt Catalent stock’s performance, he said.VF CorpCramer said he has no faith in the apparel stock’s ability to rally in the current inflationary environment.Disclaimer: Cramer’s Charitable Trust owns shares of Eli Lilly.Jim Cramer’s Guide to InvestingClick here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Show More

Related Articles

Close